Cantourage Group SE Strengthens Leadership and Expands in Europe

Cantourage Group SE is bolstering its leadership with Monique Jaqqam as the new CFO starting January 2026 and extending CEO Philip Schetter's contract for five more years. This strategic move aims to enhance the company's governance and support its growth trajectory. Jaqqam's experience in finance transformation and organizational restructuring will be instrumental in improving Cantourage’s internal capabilities.

The company anticipates strong FY25 results, with an expected sales increase to €89 million and EBITDA of €4.9 million, despite challenges in the German market. Germany’s regulatory environment regarding cannabis prescriptions is evolving, but Cantourage is adapting by diversifying its product offering and growing its presence in other markets like the UK and Poland.

In the UK, Cantourage has delivered 1.5 tons of medical cannabis, contributing to its expanding European footprint. This diversification reduces dependency on the German market and introduces new growth avenues. The company's strategic expansions are expected to position it well for future growth.